期刊文献+

特发性膜性肾病诊断与治疗的新认识 被引量:8

原文传递
导出
摘要 膜性肾病(MN)是成人非糖尿病患者肾病综合征最常见的病因,占肾活检病理诊断的1/3,其中特发性膜性肾病(IMN)约占其中的60%~75%,其余见于各种继发病因,如系统性红斑狼疮、病毒感染、药物和肿瘤等。尽管血清学检查、药物接触史或肿瘤病史可能对病因有所提示,但通常无法完全鉴别特发和继发性膜性肾病。
出处 《临床内科杂志》 CAS 2014年第5期293-296,共4页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献13

  • 1Murtas C,Bruschi M,Candiano G,et al.Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy[J] .Clin J Am Soc Nephrol,2012,7(9):1394-1400.
  • 2Beck LH,Jr Fervenza FC,Beck DM,et al.Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy[J] .J Am Soc Nephrol,2011,22(8):1543-1550.
  • 3Svobodova B,Honsova E,Ronco P,et al.Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy[J] .Nephrol Dial Transplant,2013,28(7):1839-1844.
  • 4李超,李航,文煜冰,李学旺.血清抗核抗体阳性的不典型膜性肾病与狼疮膜性肾病及特发性膜性肾病的临床病理比较[J].中华肾脏病杂志,2008,24(6):398-404. 被引量:14
  • 5管音,李航,罗娜,李超,段琳,李艳,文煜冰,李学旺.肾小球免疫荧光IgG亚型在特发性膜性肾病和继发性膜性肾病中的不同表现[J].中华肾脏病杂志,2014,30(2):85-91. 被引量:35
  • 6Schieppati A,Mosconi L,Perna A,et al.Prognosis of untreated patients with idiopathic membranous nephropathy[J] .N Engl J Med,1993,329(2):85-89.
  • 7Polanco N,Gutierrez E,Covarsi A,et al.Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy[J] .J Am Soc Nephrol,2010,21 (4):697-704.
  • 8Lionaki S,Derebail VK,Hogan SL,et al.Venous thromboembolism in patients with membranous nephropathy[J] .Clin J Am Soc Nephrol,2012,7(1):43-51.
  • 9Hladunewich MA,Troyanov S,Calafati J,et al.The natural history of the non-nephrotic membranous nephropathy patient[J] .Clin J Am Soc Nephrol,2009,4(9):1417-1422.
  • 10Jha V,Ganguli A,Saha TK,et al.A randomized,controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.J Am Soc Nephrol,2007,18(6):1899-1904.

二级参考文献23

  • 1Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol, 2001,19:403-409.
  • 2Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 2003,349: 1526-1533.
  • 3Ganczarczyk L, Urowitz MB, Gladman DD. "Latent lupus". J Rheumatol, 1989,16:475-478.
  • 4Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med, 1989,149:2473-2476.
  • 5Stahl Hallengren C, Nived O, Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus, 2004,13:85-88.
  • 6Markowitz GS. Membranous glomerulopathy: emphasis on secondary forms and disease variants. Adv Anat Pathol, 2001,8:119-125.
  • 7Jennette JC, Iskandar SS, Dalldod FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int, 1983,24:377-385.
  • 8Lai FM, To KF, Wang AY, et al. Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities. Mod Pathol, 2000,13:166-172.
  • 9Haas M. IgG subclass deposits in glomemli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis, 1994,23:358-364.
  • 10Doi T, Mayumi M, Kanatsu K, et al. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol, 1984,58:57-62.

共引文献44

同被引文献77

  • 1高伟,程小红,郭亚平.肾复康Ⅱ号胶囊联合激素、环磷酰胺治疗特发性膜性肾病临床观察[J].医学信息(医学与计算机应用),2014,0(13):147-147. 被引量:4
  • 2梁润梅.硒蛋白及其生物学功能[J].生物学教学,2004,29(9):5-7. 被引量:8
  • 3黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 4卢雪红,刘树军,罗萍,等.长疗程他克莫司联合激素治疗特发性膜性肾病的疗效和安全性[C]//中华医学会肾脏病学分会2010学术年会论文集,2010:378.
  • 5Li LS,Liu ZH.Epidemiologic date of renal disease from a single unit in China:analysis based on 13519 renal biopsies[J].Kidney Int,2004,66:920-923.
  • 6Schieppat:A,Mosconi L,Pema A,et al.Prognosis of untreated patients with idiopathic membranous nephropathy[J].N Ens l J Med,1993,329:85.
  • 7Mufihead N.Management of idiopathic membranous nephropathy:evidence-based recommendations[J].Kidney lnt,1999,S70:S47.
  • 8Jadad AR,Morr RA,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary[J].Control Clin Trials,1996,17(1):1-12.
  • 9刘鸣.系统评价Meta-分析设计与实施[M].北京:人民卫生出版社,2014:97-117.
  • 10Susan L H,Keith E M,Charles J,et al.A review of therapeutic studies of idiopathic membranous glomerulopthy[J].Am J Kidney Dis,1995,25(6):862.

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部